Valneva SE (VALN) stock
VALNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$5.34−0.23 (-4.04%)
Close on Nov 18, 2026Market cap $463.35MP/E –Yield –
Valneva operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Valneva's operating income for the twelve months ending Jun 30, 2026 was -€115.11M. For fiscal 2025 it was -€82.06M, down 715.6% from the year before. The highest annual figure on record is €13.33M in fiscal 2024.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -€82.06M | -715.6% |
| FY2024 | Dec 31, 2024 | €13.33M | – |
| FY2023 | Dec 31, 2023 | -€82.09M | – |
| FY2022 | Dec 31, 2022 | -€113.44M | – |
| FY2021 | Dec 31, 2021 | -€61.39M | – |
| FY2020 | Dec 31, 2020 | -€55.12M | – |
| FY2019 | Dec 31, 2019 | -€811.00K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -€26.19M | – |
| Q1 FY2026 | Mar 31, 2026 | -€23.70M | – |
| Q4 FY2025 | Dec 31, 2025 | -€28.12M | – |
| Q3 FY2025 | Sep 30, 2025 | -€37.12M | – |
| Q2 FY2025 | Jun 30, 2025 | -€10.87M | – |
| Q1 FY2025 | Mar 31, 2025 | -€5.96M | -108.7% |
| Q4 FY2024 | Dec 31, 2024 | -€20.88M | – |
| Q3 FY2024 | Sep 30, 2024 | -€12.45M | – |
| Q2 FY2024 | Jun 30, 2024 | -€21.55M | – |
| Q1 FY2024 | Mar 31, 2024 | €68.21M | – |
| Q4 FY2023 | Dec 31, 2023 | -€24.91M | – |
| Q3 FY2023 | Sep 30, 2023 | -€22.21M | -123.8% |
| Q2 FY2023 | Jun 30, 2023 | -€18.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -€16.57M | – |
| Q4 FY2022 | Dec 31, 2022 | -€56.35M | -132.0% |
| Q3 FY2022 | Sep 30, 2022 | €93.32M | – |
| Q2 FY2022 | Jun 30, 2022 | -€131.99M | – |
| Q1 FY2022 | Mar 31, 2022 | -€18.42M | – |
| Q4 FY2021 | Dec 31, 2021 | €176.21M | – |
| Q3 FY2021 | Sep 30, 2021 | -€151.43M | – |
| Q2 FY2021 | Jun 30, 2021 | -€55.03M | – |
| Q1 FY2021 | Mar 31, 2021 | -€31.14M | – |
See a number that looks wrong?